Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $17.2600 (3.11%) ($16.8200 - $17.3500) on Wed. Apr. 3, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.41% (three month average) | RSI | 65 | Latest Price | $17.2600(3.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 2.1% a day on average for past five trading days. | Weekly Trend | HALO advances 0.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(54%) IWM(50%) XBI(50%) IWC(49%) | Factors Impacting HALO price | HALO will decline at least -1.205% in a week (0% probabilities). VXX(-14%) UUP(-14%) VIXM(-5%) TLT(-5%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.205% (StdDev 2.41%) | Hourly BBV | 0 () | Intraday Trend | 2.3% | | | |
|
5 Day Moving Average | $16.45(4.92%) | 10 Day Moving Average | $16.16(6.81%) | 20 Day Moving Average | $16.14(6.94%) | To recent high | -1.8% | To recent low | 23.8% | Market Cap | $2.359b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |